| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | KATNAL2 MYH8 ABCF1 SPG7 ATRX MYH7B CHD9 CHD8 RFC1 DDX55 DDX1 DHX8 ACSL3 ACSL4 NAV3 ACIN1 TNNT2 | 5.98e-06 | 614 | 155 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphatidic acid binding | 3.29e-05 | 24 | 155 | 4 | GO:0070300 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KATNAL2 MYH8 ABCF1 SPG7 ATRX CHD9 CHD8 RFC1 DDX55 DDX1 DHX8 NAV3 ACIN1 | 4.15e-05 | 441 | 155 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | palmitoyl-CoA ligase activity | 1.79e-04 | 3 | 155 | 2 | GO:0090433 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.89e-04 | 37 | 155 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.10e-04 | 38 | 155 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | protein domain specific binding | NOLC1 NCOA6 HIVEP1 WIPF1 ATRX POU3F3 CHD8 RFC1 SSTR2 RCC2 AFAP1L1 ACSL3 SHCBP1 DLG1 RAPGEF2 RIMS2 GABRR3 | 4.65e-04 | 875 | 155 | 17 | GO:0019904 |
| GeneOntologyMolecularFunction | chromatin binding | NCOA6 ATRX NAP1L1 SAP30L CHD8 BRD3 JMJD1C DDX1 DNAJC2 PSIP1 KAT6B TSPYL4 TASOR STAG2 BAHCC1 | 6.50e-04 | 739 | 155 | 15 | GO:0003682 |
| Domain | NPIP | 6.95e-08 | 14 | 155 | 5 | IPR009443 | |
| Domain | WD40_repeat_dom | FBXW10B FBXW10 TAF1C UBR4 KATNB1 NBEA LYST WDR87 DNAI4 WDR44 BRWD1 | 3.89e-05 | 297 | 155 | 11 | IPR017986 |
| Domain | - | FBXW10B FBXW10 TAF1C KATNB1 NBEA PLXNB2 LYST WDR87 DNAI4 WDR44 BRWD1 | 1.08e-04 | 333 | 155 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | FBXW10B FBXW10 TAF1C KATNB1 NBEA PLXNB2 LYST WDR87 DNAI4 WDR44 BRWD1 | 1.14e-04 | 335 | 155 | 11 | IPR015943 |
| Domain | EF-hand_like | 2.37e-04 | 15 | 155 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 2.37e-04 | 15 | 155 | 3 | PF00387 | |
| Domain | PLCYc | 2.37e-04 | 15 | 155 | 3 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 2.37e-04 | 15 | 155 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 2.37e-04 | 15 | 155 | 3 | PS50008 | |
| Domain | PI-PLC_fam | 2.37e-04 | 15 | 155 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 2.37e-04 | 15 | 155 | 3 | IPR015359 | |
| Domain | Helicase_C | 2.69e-04 | 107 | 155 | 6 | PF00271 | |
| Domain | HELICc | 2.69e-04 | 107 | 155 | 6 | SM00490 | |
| Domain | Helicase_C | 2.83e-04 | 108 | 155 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 2.97e-04 | 109 | 155 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.97e-04 | 109 | 155 | 6 | PS51192 | |
| Domain | DEXDc | 2.97e-04 | 109 | 155 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.12e-04 | 110 | 155 | 6 | IPR014001 | |
| Domain | WD40 | 3.19e-04 | 259 | 155 | 9 | PF00400 | |
| Domain | WD40 | 4.10e-04 | 268 | 155 | 9 | SM00320 | |
| Domain | PI-PLC-X | 4.17e-04 | 18 | 155 | 3 | PF00388 | |
| Domain | PLCXc | 4.17e-04 | 18 | 155 | 3 | SM00148 | |
| Domain | WD40_repeat | 4.56e-04 | 272 | 155 | 9 | IPR001680 | |
| Domain | PIPLC_X_DOMAIN | 4.93e-04 | 19 | 155 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 4.93e-04 | 19 | 155 | 3 | IPR000909 | |
| Domain | WD_REPEATS_1 | 5.34e-04 | 278 | 155 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 5.48e-04 | 279 | 155 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 5.48e-04 | 279 | 155 | 9 | PS50294 | |
| Domain | DDE_Tnp_1_7 | 6.73e-04 | 5 | 155 | 2 | PF13843 | |
| Domain | PGBD | 6.73e-04 | 5 | 155 | 2 | IPR029526 | |
| Domain | AAA | 9.06e-04 | 52 | 155 | 4 | PF00004 | |
| Domain | BRK | 1.00e-03 | 6 | 155 | 2 | SM00592 | |
| Domain | PH_BEACH | 1.00e-03 | 6 | 155 | 2 | PF14844 | |
| Domain | BRK_domain | 1.00e-03 | 6 | 155 | 2 | IPR006576 | |
| Domain | BRK | 1.00e-03 | 6 | 155 | 2 | PF07533 | |
| Domain | PH_12 | 1.00e-03 | 6 | 155 | 2 | PF16457 | |
| Domain | ATPase_AAA_core | 1.05e-03 | 54 | 155 | 4 | IPR003959 | |
| Domain | - | 1.13e-03 | 25 | 155 | 3 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 1.13e-03 | 25 | 155 | 3 | IPR017946 | |
| Domain | ZnF_UBR1 | 1.40e-03 | 7 | 155 | 2 | SM00396 | |
| Domain | ZF_UBR | 1.40e-03 | 7 | 155 | 2 | PS51157 | |
| Domain | zf-UBR | 1.40e-03 | 7 | 155 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.40e-03 | 7 | 155 | 2 | IPR003126 | |
| Domain | PH-BEACH_dom | 1.85e-03 | 8 | 155 | 2 | IPR023362 | |
| Domain | - | 1.85e-03 | 8 | 155 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.85e-03 | 8 | 155 | 2 | PS51783 | |
| Domain | ARM-type_fold | 2.13e-03 | 339 | 155 | 9 | IPR016024 | |
| Domain | SNF2_N | 2.33e-03 | 32 | 155 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.33e-03 | 32 | 155 | 3 | PF00176 | |
| Domain | BEACH | 2.37e-03 | 9 | 155 | 2 | PS50197 | |
| Domain | Beach | 2.37e-03 | 9 | 155 | 2 | PF02138 | |
| Domain | - | 2.37e-03 | 9 | 155 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.37e-03 | 9 | 155 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.37e-03 | 9 | 155 | 2 | IPR000409 | |
| Domain | P-loop_NTPase | HBS1L KATNAL2 MYH8 ABCF1 SPG7 ATRX MYH7B CHD9 CHD8 RFC1 DDX55 DDX1 DHX8 NAV3 DLG1 | 4.69e-03 | 848 | 155 | 15 | IPR027417 |
| Domain | G-protein_beta_WD-40_rep | 5.49e-03 | 85 | 155 | 4 | IPR020472 | |
| Domain | WH2 | 5.83e-03 | 14 | 155 | 2 | SM00246 | |
| Domain | PDZ | 6.46e-03 | 141 | 155 | 5 | PF00595 | |
| Domain | C2 | 6.65e-03 | 142 | 155 | 5 | PS50004 | |
| Domain | Myosin_N | 6.69e-03 | 15 | 155 | 2 | PF02736 | |
| Domain | Myosin_N | 6.69e-03 | 15 | 155 | 2 | IPR004009 | |
| Domain | AAA | 7.05e-03 | 144 | 155 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 7.05e-03 | 144 | 155 | 5 | IPR003593 | |
| Domain | - | 7.38e-03 | 48 | 155 | 3 | 2.60.120.10 | |
| Domain | GATA_ZN_FINGER_1 | 7.61e-03 | 16 | 155 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 7.61e-03 | 16 | 155 | 2 | PS50114 | |
| Domain | WH2 | 7.61e-03 | 16 | 155 | 2 | PF02205 | |
| Domain | - | 7.89e-03 | 148 | 155 | 5 | 2.60.40.150 | |
| Domain | PDZ | 7.89e-03 | 148 | 155 | 5 | SM00228 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 ELOA NCOA6 ABCF1 RAPGEF6 HIVEP1 ERCC5 HIRIP3 ATRX RBBP6 SAP30L BRD3 RFC1 FANCD2 ACSL3 WWC2 PSIP1 SHCBP1 MKI67 ZNF638 ACIN1 DLG1 KAT6B STAG2 CNOT3 NOTCH2 WDR44 | 9.78e-16 | 774 | 168 | 27 | 15302935 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 ZNF131 ELOA NCOA6 HIVEP1 ATRX CENPC RBBP6 NOP53 ZNF174 KTN1 CHD8 RBM28 RFC1 PPIA CWC22 JMJD1C RCC2 DDX1 PSIP1 UTP11 PRRC2C MKI67 ZNF638 ACIN1 PUM3 TASOR STAG2 RBM17 | 2.67e-15 | 954 | 168 | 29 | 36373674 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 ZNF131 ELOA ABCF1 RAPGEF6 ATRX DSG1 RBBP6 KTN1 NAP1L1 RFC1 MDH2 PPIA RCC2 FABP5 CSDE1 FAM193A PSIP1 PRRC2C BUB1B MKI67 ZNF638 ACIN1 TASOR WDR44 RBM17 | 6.34e-13 | 934 | 168 | 26 | 33916271 |
| Pubmed | NOLC1 ELOA MYH8 PHACTR2 ERCC5 ATRX ARMC3 CENPC MYH7B ZNF174 KTN1 UBR4 BRD3 MDH2 DDX55 C2orf78 LYST DDX1 ACSL3 ACSL4 NRXN3 PSIP1 PRRC2C ACIN1 DLG1 PLCH1 RIMS2 KIAA2012 TASOR STAG2 BAHCC1 | 2.60e-12 | 1442 | 168 | 31 | 35575683 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 ELOA ABCF1 DSG1 RBBP6 NOP53 NAP1L1 PNO1 RBM28 RFC1 DDX55 PPIA CWC22 RCC2 DDX1 DNAJC2 AFAP1L1 DHX8 CSDE1 PSIP1 UTP11 PRRC2C MKI67 ZNF638 GATAD1 ACIN1 DLG1 PUM3 | 1.50e-11 | 1257 | 168 | 28 | 36526897 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF131 ELOA HIVEP1 HIRIP3 ATRX CENPC ZNF174 CHD9 CHD8 BRD3 RFC1 DDX55 JMJD1C DHX8 PSIP1 MKI67 GATAD1 PUM3 STAG2 BRWD1 | 1.92e-11 | 608 | 168 | 20 | 36089195 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 ELOA ABCF1 RBBP6 NOP53 KTN1 PNO1 RBM28 RFC1 DDX55 RCC2 DDX1 DHX8 CSDE1 MED4 PSIP1 PRRC2C MKI67 ACIN1 PUM3 TASOR RBM17 | 2.04e-11 | 759 | 168 | 22 | 35915203 |
| Pubmed | NOLC1 HIRIP3 RBBP6 NAP1L1 CHD8 BRD3 CWC22 RCC2 DDX1 KMT2C PRRC2C ZNF638 ACIN1 RBM17 | 2.53e-11 | 251 | 168 | 14 | 31076518 | |
| Pubmed | NOLC1 ZNF131 NCOA6 ABCF1 HIVEP1 WIPF1 ZNF174 NAP1L1 CHD9 CHD8 RBM28 RFC1 DDX55 JMJD1C RCC2 DDX1 CSDE1 KMT2C MED4 PSIP1 PRRC2C MKI67 PUM3 STAG2 RBM17 | 1.46e-10 | 1103 | 168 | 25 | 34189442 | |
| Pubmed | MAPKAP1 HBS1L ABCF1 RAPGEF6 ATRX CHD8 DDX55 CWC22 JMJD1C RCC2 DDX1 CSDE1 PRRC2C SHCBP1 BUB1B ZNF638 DLG1 PLCH1 TASOR | 4.57e-10 | 650 | 168 | 19 | 38777146 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 NCOA6 HIRIP3 ATRX RBBP6 TAF1C KTN1 SAP30L BRD3 RBM28 RFC1 JMJD1C RCC2 DHX8 ACSL3 KMT2C MED4 PSIP1 ARID5B MKI67 ZNF638 GATAD1 ACIN1 TASOR STAG2 RBM17 | 7.86e-10 | 1294 | 168 | 26 | 30804502 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 TUT4 ABCF1 RBBP6 NOP53 NAP1L1 PNO1 RBM28 MDH2 PPIA RCC2 DDX1 DHX8 CSDE1 PSIP1 UTP11 PRRC2C ZNF638 ACIN1 PUM3 | 2.64e-09 | 807 | 168 | 20 | 22681889 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | NOLC1 ELOA ATRX CENPC NAP1L1 JMJD1C MKI67 ZNF638 ACIN1 TASOR | 3.03e-09 | 148 | 168 | 10 | 32538781 |
| Pubmed | NOLC1 SPG7 DSG1 RBBP6 NOP53 NAP1L1 PNO1 RBM28 MDH2 DDX55 PPIA CWC22 RCC2 FABP5 PSIP1 PRRC2C ACIN1 PUM3 RBM17 | 3.14e-09 | 731 | 168 | 19 | 29298432 | |
| Pubmed | NOLC1 ABCF1 NOP53 UBR4 NAP1L1 CHD8 RBM28 RFC1 RCC2 DHX8 CSDE1 ACSL3 PRRC2C MKI67 ZNF638 ACIN1 PUM3 STAG2 | 3.37e-09 | 653 | 168 | 18 | 22586326 | |
| Pubmed | KATNAL2 CCPG1 RBBP6 NOP53 TAF1C KTN1 NAP1L1 BRD3 RBM28 RFC1 DDX55 DDX1 DHX8 PSIP1 MKI67 ZNF638 ACIN1 PUM3 TASOR RBM17 | 5.95e-09 | 847 | 168 | 20 | 35850772 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOLC1 ELOA ABCF1 DSG1 PNO1 RBM28 RFC1 DDX55 DDX1 FABP5 PSIP1 PRRC2C MKI67 ZNF638 ACIN1 PUM3 RBM17 | 7.12e-09 | 605 | 168 | 17 | 28977666 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAPKAP1 NOLC1 NCOA6 PHACTR2 RAPGEF6 HIVEP1 SASH1 LYST DDX1 HAUS8 WWC2 BMPR2 DENND1B KCNQ5 TIAM1 PRRC2C BUB1B RAPGEF2 PLCH1 NOTCH2 | 7.82e-09 | 861 | 168 | 20 | 36931259 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NOLC1 ABCF1 ATRX CENPC NOP53 PNO1 CHD9 CHD8 BRD3 RFC1 CWC22 MED4 PSIP1 MKI67 ACIN1 PLCH1 | 8.03e-09 | 533 | 168 | 16 | 30554943 |
| Pubmed | NOLC1 ATRX RBBP6 NOP53 NAP1L1 CHD8 BRD3 RFC1 HAUS8 KMT2C PSIP1 PRRC2C ZNF638 ACIN1 TASOR | 1.04e-08 | 469 | 168 | 15 | 27634302 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ELOA NCOA6 ATRX RBBP6 CHD8 RFC1 JMJD1C DHX8 PSIP1 MKI67 ZNF638 ACIN1 | 1.53e-08 | 283 | 168 | 12 | 30585729 |
| Pubmed | MAPKAP1 HBS1L KATNAL2 ABCF1 ATRX RBBP6 NOP53 TAF1C KTN1 NAP1L1 PNO1 CHD8 BRD3 DDX55 RCC2 DNAJC2 DHX8 CSDE1 KMT2C MED4 GATAD1 DLG1 PUM3 TASOR STAG2 CNOT3 | 1.58e-08 | 1497 | 168 | 26 | 31527615 | |
| Pubmed | NOLC1 ELOA ATRX CENPC RBBP6 UBR4 NAP1L1 CHD9 CHD8 BRD3 RFC1 DDX1 FABP5 FANCD2 CSDE1 MED4 PSIP1 MKI67 ACIN1 STAG2 RBM17 | 2.33e-08 | 1014 | 168 | 21 | 32416067 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 HBS1L ABCF1 HIVEP1 ATRX DSG1 NOP53 KTN1 UBR4 NAP1L1 RFC1 MDH2 DDX55 PPIA CWC22 RCC2 DDX1 DHX8 FANCD2 ACSL3 PSIP1 MKI67 ACIN1 PUM3 STAG2 | 2.54e-08 | 1425 | 168 | 25 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 HBS1L ABCF1 CENPC DSG1 TAF1C KTN1 UBR4 NAP1L1 PNO1 CHD8 RBM28 RFC1 PPIA DDX1 FABP5 CSDE1 ACSL3 ACSL4 SHCBP1 MKI67 ZNF638 ACIN1 PUM3 | 4.05e-08 | 1353 | 168 | 24 | 29467282 |
| Pubmed | NCOA6 HBS1L RAPGEF6 RBBP6 KTN1 NAP1L1 CHD8 JMJD1C CSDE1 KMT2C PRRC2C BUB1B ACIN1 DLG1 WDR44 | 8.20e-08 | 549 | 168 | 15 | 38280479 | |
| Pubmed | NOLC1 ELOA ABCF1 NOP53 PNO1 RBM28 RFC1 DDX55 DHX8 UTP11 PRRC2C MKI67 ZNF638 PUM3 | 1.10e-07 | 483 | 168 | 14 | 36912080 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NOLC1 NCOA6 RBBP6 UBR4 CHD8 RBM28 JMJD1C MKI67 ZNF638 ACIN1 KAT6B RBM17 | 1.17e-07 | 341 | 168 | 12 | 32971831 |
| Pubmed | LDLRAP1 ABCF1 ATRX TAF1C UBR4 NAP1L1 CHD9 NBEA ZNF302 RYR3 CSDE1 MED4 TIAM1 ARID5B NAV3 DLG1 TMEM131 ANKRD36 SMPD3 RAPGEF2 CNOT3 BRWD1 | 2.87e-07 | 1285 | 168 | 22 | 35914814 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 ELOA KATNAL2 CENPC DSG1 NOP53 NAP1L1 PNO1 RBM28 RFC1 PPIA CWC22 JMJD1C DDX1 UTP11 MKI67 ZNF638 ACIN1 PUM3 | 3.59e-07 | 989 | 168 | 19 | 36424410 |
| Pubmed | ELOA ABCF1 RBBP6 NAP1L1 RBM28 RFC1 RCC2 DDX1 DHX8 CSDE1 PSIP1 PRRC2C MKI67 ZNF638 ACIN1 RBM17 | 4.24e-07 | 713 | 168 | 16 | 29802200 | |
| Pubmed | NOLC1 ZNF131 NCOA6 HIVEP1 ATRX RBBP6 NOP53 UBR4 CHD8 RBM28 RFC1 JMJD1C RCC2 DDX1 KMT2C MED4 PRRC2C ARID5B MKI67 ZNF638 GATAD1 PUM3 CNOT3 | 4.42e-07 | 1429 | 168 | 23 | 35140242 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 ABCF1 DSG1 NAP1L1 RBM28 MDH2 PLXNB2 PPIA RCC2 DDX1 DHX8 ACSL3 PSIP1 MKI67 ZNF638 ACIN1 PUM3 STAG2 RBM17 | 6.04e-07 | 1024 | 168 | 19 | 24711643 |
| Pubmed | NOLC1 NCOA6 ABCF1 RBBP6 KTN1 PNO1 CHD9 RFC1 MDH2 PPIA RCC2 DDX1 FABP5 DHX8 MED4 WDR87 MKI67 ACIN1 DLG1 CNOT3 RBM17 | 7.15e-07 | 1247 | 168 | 21 | 27684187 | |
| Pubmed | 7.27e-07 | 103 | 168 | 7 | 32744500 | ||
| Pubmed | HBS1L ABCF1 RBBP6 NOP53 PNO1 RBM28 DDX55 RCC2 DDX1 CSDE1 ACSL3 ZNF469 PSIP1 WDR44 RBM17 | 7.41e-07 | 653 | 168 | 15 | 33742100 | |
| Pubmed | NOLC1 ABCF1 DSG1 RBBP6 NAP1L1 RBM28 RFC1 PPIA RCC2 CSDE1 FAM193A PRRC2C MKI67 ACIN1 PUM3 | 7.69e-07 | 655 | 168 | 15 | 35819319 | |
| Pubmed | ELOA CENPC NOP53 ZNF174 NBEA BRD3 FANCD2 ACSL3 ACSL4 WWC2 PPP2R3A MED4 TIAM1 PTPRZ1 PLCL2 MKI67 ZNF638 UBR3 DLG1 | 8.65e-07 | 1049 | 168 | 19 | 27880917 | |
| Pubmed | MAPKAP1 NOLC1 ZNF131 CCPG1 ABCF1 ATRX CENPC KTN1 UBR4 RBM28 MDH2 PLXNB2 DNAJC2 ACSL3 MED4 FAM193A PSIP1 TIAM1 BUB1B DLG1 TMEM131 PLCH1 NOTCH2 | 8.76e-07 | 1487 | 168 | 23 | 33957083 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 KATNAL2 ABCF1 DSG1 RBBP6 NOP53 NAP1L1 RBM28 DDX55 PPIA RCC2 DDX1 DHX8 CSDE1 PSIP1 UTP11 MKI67 RBM17 | 8.92e-07 | 949 | 168 | 18 | 36574265 |
| Pubmed | PPP1R21 HBS1L ABCF1 KTN1 UBR4 KATNB1 NAP1L1 PEX13 DDX55 PPIA DDX1 ACSL3 ACSL4 MED4 PRRC2C DEF6 MKI67 STAG2 IL6ST NOTCH2 | 1.04e-06 | 1168 | 168 | 20 | 19946888 | |
| Pubmed | 1.13e-06 | 215 | 168 | 9 | 35973513 | ||
| Pubmed | NOLC1 ABCF1 HIRIP3 RBBP6 NAP1L1 CHD8 RFC1 SHCBP1 MKI67 ZNF638 ACIN1 TMEM131 WDR44 | 1.15e-06 | 503 | 168 | 13 | 16964243 | |
| Pubmed | NOLC1 HBS1L RAPGEF6 ERCC5 SPG7 ATRX RBM28 KMT2C WWC2 PLCL2 ARID5B ZNF638 ACIN1 DLG1 TMEM131 TASOR STAG2 LRRC71 BRWD1 | 1.40e-06 | 1084 | 168 | 19 | 11544199 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 HBS1L ABCF1 ERCC5 DSG1 KTN1 UBR4 NAP1L1 PNO1 RFC1 MDH2 DDX55 PPIA RCC2 DDX1 DNAJC2 DHX8 CSDE1 PSIP1 PRRC2C ZNF638 STAG2 | 1.42e-06 | 1415 | 168 | 22 | 28515276 |
| Pubmed | NOLC1 NCOA6 SASH1 CHD8 DDX55 CWC22 GRAMD4 RCC2 KMT2C NRXN3 PLCH2 KAT6B RIMS2 | 2.00e-06 | 529 | 168 | 13 | 14621295 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | CCPG1 ABCF1 KTN1 PLXNB2 JMJD1C GRAMD4 COLEC12 PSIP1 PRRC2C TMEM131 NOTCH2 | 2.36e-06 | 375 | 168 | 11 | 32788342 |
| Pubmed | ELOA TUT4 KTN1 PEX13 RBM28 JMJD1C AFAP1L1 DHX8 HAUS8 FAM193A ZNF638 DLG1 TMEM131 PLCH1 TASOR | 3.06e-06 | 733 | 168 | 15 | 34672954 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | HBS1L ATRX DSG1 UBR4 CHD8 MDH2 RCC2 DNAJC2 FAM193A PRRC2C NAV3 RAPGEF2 | 3.79e-06 | 475 | 168 | 12 | 31040226 |
| Pubmed | 4.24e-06 | 87 | 168 | 6 | 12465718 | ||
| Pubmed | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 4.25e-06 | 134 | 168 | 7 | 28695742 | |
| Pubmed | 4.28e-06 | 253 | 168 | 9 | 29911972 | ||
| Pubmed | MAPKAP1 HBS1L CCPG1 RBBP6 NOP53 UBR4 PNO1 RFC1 MDH2 DDX55 PLXNB2 PPIA CSDE1 ACSL3 PSIP1 PRRC2C MKI67 CNOT3 NOTCH2 RBM17 | 5.04e-06 | 1297 | 168 | 20 | 33545068 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 5.17e-06 | 90 | 168 | 6 | 35654790 | |
| Pubmed | 5.23e-06 | 195 | 168 | 8 | 19454010 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | NOLC1 LDLRAP1 RNF130 ATRX CHD8 DDX1 DHX8 FANCD2 BUB1B ZNF638 ACIN1 STAG2 RBM17 | 5.64e-06 | 582 | 168 | 13 | 20467437 |
| Pubmed | MYH8 HIVEP1 WIPF1 KTN1 NAP1L1 ZNF302 JMJD1C PUM3 WIPF2 STAG2 IL6ST NOTCH2 | 6.00e-06 | 497 | 168 | 12 | 23414517 | |
| Pubmed | NOLC1 NOP53 KTN1 UBR4 NAP1L1 RBM28 RFC1 MDH2 RCC2 DDX1 FANCD2 CSDE1 ACSL3 PSIP1 PRRC2C BUB1B MKI67 PUM3 STAG2 CNOT3 RBM17 | 6.76e-06 | 1440 | 168 | 21 | 30833792 | |
| Pubmed | 6.77e-06 | 419 | 168 | 11 | 15635413 | ||
| Pubmed | MAPKAP1 LDLRAP1 RNF130 ELOA MYH8 ATRX CENPC SLC26A2 UBR4 CHD8 DDX55 FANCD2 ACSL3 KMT2C MED4 FAM193A ARID5B GATAD1 PUM3 SDHAF4 | 7.05e-06 | 1327 | 168 | 20 | 32694731 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 7.45e-06 | 271 | 168 | 9 | 32433965 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | HBS1L ERCC5 HIRIP3 DSG1 RBBP6 BRD3 PPIA DHX8 FANCD2 ACSL3 MED4 ACIN1 SETD3 CNOT3 | 7.90e-06 | 695 | 168 | 14 | 23602568 |
| Pubmed | 1.01e-05 | 101 | 168 | 6 | 10997877 | ||
| Pubmed | MAPKAP1 NOLC1 TUT4 ABCF1 DSG1 KTN1 UBR4 NBEA PPIA CSDE1 ACSL3 KCNQ5 PRRC2C NAV3 UBR3 DLG1 CNOT3 RBM17 | 1.11e-05 | 1139 | 168 | 18 | 36417873 | |
| Pubmed | ELOA DSG1 TAF1C KTN1 NAP1L1 RBM28 RFC1 MDH2 DDX55 ANKRD36B CSDE1 ACSL4 MED4 PSIP1 PRRC2C MKI67 ACIN1 PUM3 WIPF2 RBM17 | 1.13e-05 | 1371 | 168 | 20 | 36244648 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | HBS1L PHACTR2 TUT4 RAPGEF6 HIVEP1 KTN1 NAP1L1 CHD9 BRD3 NPIPB5 PLXNB2 HAUS8 FAM193A ZNF638 CNOT3 BRWD1 | 1.18e-05 | 925 | 168 | 16 | 28986522 |
| Pubmed | NOLC1 TUT4 RBBP6 NOP53 NAP1L1 PNO1 MDH2 PPIA CWC22 DDX1 DHX8 CSDE1 DENND1B RBM17 | 1.23e-05 | 723 | 168 | 14 | 34133714 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | MAPKAP1 NOLC1 HBS1L FBXW10 ABCF1 RAPGEF6 HIRIP3 NAP1L1 PNO1 CSDE1 HAUS8 WWC2 DENND1B BUB1B RAPGEF2 CNOT3 RBM17 | 1.26e-05 | 1038 | 168 | 17 | 26673895 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.79e-05 | 231 | 168 | 8 | 16452087 | |
| Pubmed | RAPGEF6 KTN1 MDH2 PPIA ACSL3 ACSL4 BMPR2 TIAM1 PLCH1 IL6ST NOTCH2 | 1.86e-05 | 467 | 168 | 11 | 30194290 | |
| Pubmed | NOLC1 ATRX DSG1 RBBP6 MDH2 PPIA FABP5 FANCD2 PSIP1 MKI67 ZNF638 PUM3 STAG2 | 1.87e-05 | 652 | 168 | 13 | 31180492 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 ELOA ABCF1 RBBP6 CHD9 BRD3 DDX55 PPIA CWC22 RCC2 DDX1 DHX8 PSIP1 PTPRO ZNF638 ACIN1 RBM17 | 2.13e-05 | 1082 | 168 | 17 | 38697112 |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 30396924 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24858808 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 32286604 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20071355 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 29450800 | ||
| Pubmed | Identification of a novel class of mammalian phosphoinositol-specific phospholipase C enzymes. | 2.32e-05 | 2 | 168 | 2 | 15583837 | |
| Pubmed | Identification of novel loci for bipolar I disorder in a multi-stage genome-wide association study. | 2.32e-05 | 2 | 168 | 2 | 24444492 | |
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 2.32e-05 | 2 | 168 | 2 | 31400758 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27009365 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 37450367 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 1552844 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21808054 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 28193492 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 32600317 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.39e-05 | 394 | 168 | 10 | 27248496 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 2.52e-05 | 316 | 168 | 9 | 31665637 | |
| Pubmed | HIVEP1 WIPF1 RBBP6 KTN1 CHD8 CSDE1 KMT2C NAV3 RAPGEF2 WIPF2 WDR44 | 2.67e-05 | 486 | 168 | 11 | 20936779 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 2.98e-05 | 248 | 168 | 8 | 27926873 | |
| Pubmed | 3.15e-05 | 250 | 168 | 8 | 33536335 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | HBS1L ABCF1 KTN1 UBR4 KATNB1 NAP1L1 NBEA RCC2 ACSL3 PSIP1 STAG2 | 3.34e-05 | 498 | 168 | 11 | 36634849 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.34e-05 | 184 | 168 | 7 | 32908313 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 3.35e-05 | 410 | 168 | 10 | 26949251 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | PPP1R21 SPG7 TAF1C UBR4 NAP1L1 PNO1 BRD3 RFC1 PPBP PLXNB2 JMJD1C KMT2C BMPR2 PSIP1 PTPRO FZD5 MKI67 | 3.43e-05 | 1124 | 168 | 17 | 21900206 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.70e-05 | 332 | 168 | 9 | 32786267 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.73e-05 | 256 | 168 | 8 | 33397691 | |
| Pubmed | NOLC1 PHACTR2 RBBP6 NAP1L1 MDH2 RCC2 DDX1 MKI67 ACIN1 WIPF2 RBM17 | 3.85e-05 | 506 | 168 | 11 | 30890647 | |
| Pubmed | ZNF131 RAPGEF6 HIVEP1 UBR4 CHD8 JMJD1C FAM193A BUB1B ARID5B TASOR | 3.94e-05 | 418 | 168 | 10 | 34709266 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 4.05e-05 | 259 | 168 | 8 | 30404004 | |
| Interaction | NUP43 interactions | ZNF131 NCOA6 HIVEP1 ERCC5 CENPC DSG1 RBBP6 NOP53 CHD9 CHD8 RBM28 RFC1 DDX55 CWC22 JMJD1C RCC2 DHX8 FANCD2 PSIP1 PRRC2C BUB1B MKI67 ACIN1 RAPGEF2 | 2.11e-10 | 625 | 162 | 24 | int:NUP43 |
| Interaction | SMC5 interactions | NOLC1 ZNF131 ELOA NCOA6 HIVEP1 ATRX CENPC RBBP6 NOP53 ZNF174 KTN1 CHD8 RBM28 RFC1 PPIA CWC22 JMJD1C RCC2 DDX1 TIPARP PSIP1 UTP11 PRRC2C MKI67 ZNF638 ACIN1 PUM3 TASOR STAG2 RBM17 | 3.71e-10 | 1000 | 162 | 30 | int:SMC5 |
| Interaction | H3-3A interactions | ZNF131 ELOA HIVEP1 HIRIP3 ATRX CENPC ZNF174 CHD9 CHD8 BRD3 RFC1 DDX55 JMJD1C DHX8 FANCD2 KMT2C PSIP1 TIAM1 MKI67 GATAD1 PUM3 NOS3 STAG2 BRWD1 | 7.56e-09 | 749 | 162 | 24 | int:H3-3A |
| Interaction | MEN1 interactions | NOLC1 NCOA6 KATNAL2 CCPG1 ATRX RBBP6 NOP53 TAF1C KTN1 UBR4 NAP1L1 CHD8 RBM28 RFC1 DDX55 JMJD1C DDX1 DHX8 FANCD2 KMT2C PSIP1 MKI67 ZNF638 ACIN1 PUM3 KAT6B TASOR RBM17 | 1.32e-08 | 1029 | 162 | 28 | int:MEN1 |
| Interaction | NAA40 interactions | NOLC1 ZNF131 ELOA ABCF1 RAPGEF6 ATRX DSG1 RBBP6 KTN1 NAP1L1 RFC1 MDH2 PPIA RCC2 FABP5 CSDE1 FAM193A PSIP1 PRRC2C BUB1B MKI67 ZNF638 ACIN1 TASOR WDR44 RBM17 | 7.42e-08 | 978 | 162 | 26 | int:NAA40 |
| Interaction | HECTD1 interactions | NOLC1 ELOA HBS1L ABCF1 RBBP6 NOP53 KTN1 NAP1L1 PNO1 RBM28 RFC1 DDX55 RCC2 DDX1 TIPARP DHX8 CSDE1 MED4 PSIP1 PRRC2C MKI67 ACIN1 PUM3 TASOR RBM17 | 3.20e-07 | 984 | 162 | 25 | int:HECTD1 |
| Interaction | NOP56 interactions | NOLC1 ELOA ABCF1 HIRIP3 ATRX CENPC NOP53 NAP1L1 BRD3 RBM28 RFC1 DDX55 TIPARP FANCD2 BMPR2 MED4 MKI67 PUM3 | 8.15e-07 | 570 | 162 | 18 | int:NOP56 |
| Interaction | DHX40 interactions | ELOA ERCC5 CENPC RBBP6 NOP53 KTN1 RBM28 PPIA DHX8 MED4 ZNF638 TASOR | 8.50e-07 | 249 | 162 | 12 | int:DHX40 |
| Interaction | H3C1 interactions | ELOA ATRX CENPC UBR4 NAP1L1 CHD8 BRD3 RBM28 RFC1 MDH2 JMJD1C RCC2 FANCD2 KMT2C PSIP1 PRRC2C WDR87 SHCBP1 MKI67 NAV3 ZNF638 KAT6B STAG2 | 9.24e-07 | 901 | 162 | 23 | int:H3C1 |
| Interaction | H2BC8 interactions | ELOA ERCC5 HIRIP3 ATRX CENPC ZNF174 NAP1L1 CHD8 BRD3 RFC1 DDX55 RCC2 DHX8 PSIP1 ARID5B MKI67 TASOR STAG2 | 9.47e-07 | 576 | 162 | 18 | int:H2BC8 |
| Interaction | SRPK2 interactions | NOLC1 HBS1L HIVEP1 HIRIP3 RBBP6 NOP53 TAF1C UBR4 BRD3 RBM28 PPIA JMJD1C DNAJC2 DHX8 PRRC2C MKI67 ZNF638 ACIN1 PUM3 RBM17 | 1.33e-06 | 717 | 162 | 20 | int:SRPK2 |
| Interaction | CHD4 interactions | NOLC1 ELOA ABCF1 DSG1 RBBP6 PNO1 BRD3 RBM28 RFC1 DDX55 CWC22 DDX1 TIPARP FABP5 DHX8 FANCD2 PSIP1 PRRC2C MKI67 ZNF638 ACIN1 PUM3 RBM17 | 1.83e-06 | 938 | 162 | 23 | int:CHD4 |
| Interaction | POLR1G interactions | NOLC1 ELOA CENPC NOP53 ZNF174 TAF1C UBR4 CHD9 CHD8 BRD3 RBM28 RFC1 DDX55 MED4 PUM3 STAG2 | 2.19e-06 | 489 | 162 | 16 | int:POLR1G |
| Interaction | CENPA interactions | HIVEP1 ERCC5 HIRIP3 ATRX CENPC NOP53 ZNF174 BRD3 RFC1 DDX55 PSIP1 SHCBP1 STAG2 BRWD1 | 2.28e-06 | 377 | 162 | 14 | int:CENPA |
| Interaction | H3C3 interactions | ZNF131 ELOA HIVEP1 ATRX CENPC ZNF174 CHD8 BRD3 RFC1 DDX55 JMJD1C DHX8 MKI67 GATAD1 PUM3 STAG2 | 2.56e-06 | 495 | 162 | 16 | int:H3C3 |
| Interaction | SOX2 interactions | ELOA NCOA6 HIVEP1 NOP53 UBR4 NAP1L1 PNO1 CHD9 CHD8 RBM28 RFC1 MDH2 PPIA JMJD1C DDX1 TIPARP FABP5 ACSL3 KMT2C PSIP1 SHCBP1 ARID5B NAV3 ZNF638 PUM3 PLCH1 KAT6B STAG2 CNOT3 | 3.00e-06 | 1422 | 162 | 29 | int:SOX2 |
| Interaction | SKA3 interactions | 3.95e-06 | 194 | 162 | 10 | int:SKA3 | |
| Interaction | FBL interactions | NOLC1 ELOA TUT4 NOP53 KTN1 NAP1L1 PNO1 RBM28 RFC1 DDX55 PPIA TIPARP FANCD2 CSDE1 UTP11 PRRC2C MKI67 PUM3 | 4.08e-06 | 639 | 162 | 18 | int:FBL |
| Interaction | RAD18 interactions | NOLC1 ELOA HIRIP3 RBBP6 NAP1L1 BRD3 CWC22 RCC2 DDX1 FANCD2 ACSL3 PRRC2C ZNF638 ACIN1 RBM17 | 4.45e-06 | 457 | 162 | 15 | int:RAD18 |
| Interaction | DOCK11 interactions | 6.36e-06 | 57 | 162 | 6 | int:DOCK11 | |
| Interaction | CEBPA interactions | NOLC1 ZNF131 NCOA6 ABCF1 HIVEP1 WIPF1 ZNF174 NAP1L1 CHD9 CHD8 RBM28 RFC1 DDX55 JMJD1C RCC2 DDX1 CSDE1 KMT2C MED4 PSIP1 PRRC2C MKI67 ACIN1 PUM3 STAG2 RBM17 | 6.92e-06 | 1245 | 162 | 26 | int:CEBPA |
| Interaction | ZC3H18 interactions | NOLC1 SPG7 DSG1 RBBP6 NOP53 NAP1L1 PNO1 RBM28 MDH2 DDX55 PPIA CWC22 RCC2 TIPARP FABP5 DHX8 PSIP1 PRRC2C ACIN1 PUM3 RBM17 | 7.73e-06 | 877 | 162 | 21 | int:ZC3H18 |
| Interaction | DDX23 interactions | NOLC1 ELOA CENPC RBBP6 NOP53 RBM28 MDH2 DDX55 CWC22 DHX8 FANCD2 ZNF638 ACIN1 PUM3 RBM17 | 8.02e-06 | 480 | 162 | 15 | int:DDX23 |
| Interaction | APEX1 interactions | NOLC1 ZNF131 ELOA HBS1L PHACTR2 TUT4 RAPGEF6 HIVEP1 ERCC5 CENPC NOP53 KTN1 NAP1L1 CHD9 BRD3 RFC1 NPIPB5 PLXNB2 HAUS8 FAM193A PSIP1 ZNF638 UBR3 STAG2 CNOT3 BRWD1 | 9.98e-06 | 1271 | 162 | 26 | int:APEX1 |
| Interaction | NFKBIL1 interactions | 1.01e-05 | 93 | 162 | 7 | int:NFKBIL1 | |
| Interaction | BRD3 interactions | NOLC1 ABCF1 CENPC RBBP6 TAF1C PNO1 CHD9 CHD8 BRD3 RFC1 MED4 PSIP1 MKI67 ACIN1 PLCH1 | 1.13e-05 | 494 | 162 | 15 | int:BRD3 |
| Interaction | CHD3 interactions | NOLC1 ELOA DSG1 PNO1 RBM28 RFC1 DDX55 DDX1 TIPARP FABP5 FANCD2 PSIP1 PRRC2C MKI67 GATAD1 ACIN1 PUM3 STAG2 RBM17 | 1.13e-05 | 757 | 162 | 19 | int:CHD3 |
| Interaction | IFI16 interactions | ELOA ABCF1 NOP53 KTN1 PNO1 RBM28 RFC1 DDX55 RCC2 DDX1 TIPARP DHX8 UTP11 MKI67 ZNF638 ACIN1 PUM3 TASOR | 1.84e-05 | 714 | 162 | 18 | int:IFI16 |
| Interaction | CSNK2A2 interactions | NOLC1 ELOA TUT4 ERCC5 HIRIP3 ATRX NOP53 TAF1C NAP1L1 BRD3 LYST RCC2 TIPARP ANKRD36B MED4 PRRC2C MKI67 ANKRD36 | 1.98e-05 | 718 | 162 | 18 | int:CSNK2A2 |
| Interaction | YWHAH interactions | MAPKAP1 NOLC1 NCOA6 PHACTR2 RAPGEF6 HIVEP1 SASH1 CWC22 LYST DDX1 FANCD2 HAUS8 WWC2 DENND1B KCNQ5 TIAM1 PRRC2C SHCBP1 ZNF638 RAPGEF2 PLCH1 RIMS2 NOTCH2 | 2.52e-05 | 1102 | 162 | 23 | int:YWHAH |
| Interaction | SUPT5H interactions | NOLC1 ELOA HIVEP1 WIPF1 ATRX UBR4 PNO1 PPIA JMJD1C FANCD2 CSDE1 ACIN1 TASOR | 2.70e-05 | 408 | 162 | 13 | int:SUPT5H |
| Interaction | HDAC1 interactions | NOLC1 MYH8 RAPGEF6 HIVEP1 ATRX UBR4 SAP30L CHD8 RFC1 PPIA JMJD1C DDX1 TIPARP FANCD2 SHCBP1 BUB1B ARID5B MKI67 ZNF638 GATAD1 TASOR STAG2 BAHCC1 | 2.75e-05 | 1108 | 162 | 23 | int:HDAC1 |
| Interaction | USP36 interactions | NOLC1 ELOA ABCF1 NOP53 PNO1 RBM28 RFC1 DDX55 PPIA DHX8 FANCD2 UTP11 PRRC2C MKI67 ZNF638 PUM3 | 2.76e-05 | 599 | 162 | 16 | int:USP36 |
| Interaction | DAXX interactions | NOLC1 ABCF1 ATRX CENPC CHD9 BRD3 RBM28 RFC1 PPIA BUB1B MKI67 TASOR | 2.96e-05 | 353 | 162 | 12 | int:DAXX |
| Interaction | SIRT7 interactions | NOLC1 ABCF1 NOP53 UBR4 NAP1L1 CHD8 RBM28 RFC1 RCC2 DHX8 CSDE1 ACSL3 PRRC2C MKI67 ZNF638 ACIN1 PUM3 STAG2 | 3.16e-05 | 744 | 162 | 18 | int:SIRT7 |
| Interaction | CIT interactions | NOLC1 HBS1L ABCF1 RBBP6 NOP53 KTN1 UBR4 NAP1L1 PNO1 CHD8 BRD3 RBM28 MDH2 PPIA DDX1 DHX8 ACSL3 ACSL4 PSIP1 PRRC2C MKI67 ZNF638 ACIN1 DNAI4 PUM3 STAG2 RBM17 | 3.51e-05 | 1450 | 162 | 27 | int:CIT |
| Interaction | UHRF2 interactions | 3.56e-05 | 200 | 162 | 9 | int:UHRF2 | |
| Interaction | PRC1 interactions | NOLC1 ABCF1 ATRX RBBP6 KTN1 NAP1L1 RBM28 PPIA CWC22 DDX1 TIPARP DHX8 ACSL3 COLEC12 PSIP1 MKI67 ZNF638 ACIN1 PUM3 NOTCH2 RBM17 | 3.62e-05 | 973 | 162 | 21 | int:PRC1 |
| Interaction | OBSL1 interactions | NOLC1 ABCF1 NOP53 RBM28 RFC1 MDH2 DDX55 PPIA RCC2 DDX1 DHX8 ACSL3 PSIP1 MKI67 ZNF638 ACIN1 PUM3 STAG2 NOTCH2 RBM17 | 3.87e-05 | 902 | 162 | 20 | int:OBSL1 |
| Interaction | TERF2IP interactions | ZNF131 ELOA NCOA6 HIVEP1 ERCC5 CENPC RBBP6 CHD8 RFC1 DDX55 DHX8 PSIP1 MKI67 ZNF638 TASOR | 4.08e-05 | 552 | 162 | 15 | int:TERF2IP |
| Interaction | FGFBP1 interactions | 4.52e-05 | 257 | 162 | 10 | int:FGFBP1 | |
| Interaction | PES1 interactions | NOLC1 ELOA NOP53 NAP1L1 RBM28 CWC22 TIPARP FANCD2 MKI67 PUM3 | 4.67e-05 | 258 | 162 | 10 | int:PES1 |
| Interaction | NIFK interactions | NOLC1 ELOA CENPC RBBP6 NOP53 BRD3 RBM28 RFC1 DDX55 FANCD2 MED4 MKI67 PUM3 | 4.74e-05 | 431 | 162 | 13 | int:NIFK |
| Interaction | SON interactions | 4.84e-05 | 208 | 162 | 9 | int:SON | |
| Interaction | YWHAG interactions | MAPKAP1 NOLC1 NCOA6 PHACTR2 RAPGEF6 HIVEP1 SASH1 CWC22 LYST DDX1 AFAP1L1 FANCD2 HAUS8 WWC2 DENND1B KCNQ5 TIAM1 PRRC2C SHCBP1 ZNF638 ACIN1 RAPGEF2 PLCH1 NOTCH2 | 6.12e-05 | 1248 | 162 | 24 | int:YWHAG |
| Interaction | CBX3 interactions | ZNF131 ELOA ATRX CENPC RBBP6 CHD9 CHD8 BRD3 RFC1 TIPARP DHX8 FANCD2 PSIP1 SHCBP1 MKI67 STAG2 | 6.77e-05 | 646 | 162 | 16 | int:CBX3 |
| Interaction | MKI67 interactions | ZNF131 NCOA6 NOP53 CHD8 BRD3 PPIA CWC22 TIPARP FANCD2 SHCBP1 BUB1B MKI67 ACIN1 PUM3 STAG2 RBM17 | 7.02e-05 | 648 | 162 | 16 | int:MKI67 |
| Interaction | POU5F1 interactions | TUT4 ABCF1 UBR4 POU3F3 BRD3 RFC1 PPIA JMJD1C FABP5 FANCD2 PPP2R3A PSIP1 ACIN1 BRWD1 RBM17 | 7.70e-05 | 584 | 162 | 15 | int:POU5F1 |
| Interaction | SUMO2 interactions | GCNA ABCF1 ATRX CENPC UBR4 NAP1L1 CHD8 BRD3 DDX1 FABP5 FANCD2 MKI67 ZNF638 ACIN1 STAG2 | 8.79e-05 | 591 | 162 | 15 | int:SUMO2 |
| Interaction | DOT1L interactions | ATRX RBBP6 NOP53 TAF1C KTN1 NAP1L1 BRD3 RBM28 RFC1 DDX55 DDX1 DHX8 PSIP1 MKI67 ZNF638 ACIN1 PUM3 TASOR | 8.98e-05 | 807 | 162 | 18 | int:DOT1L |
| Interaction | NPM1 interactions | HIVEP1 CENPC NOP53 TAF1C KTN1 NAP1L1 PNO1 CHD8 BRD3 RBM28 RFC1 DDX55 PPIA DDX1 DNAJC2 TIPARP FANCD2 PSIP1 PRRC2C WDR87 MKI67 ZNF638 PUM3 | 9.42e-05 | 1201 | 162 | 23 | int:NPM1 |
| Interaction | RFC4 interactions | 9.48e-05 | 227 | 162 | 9 | int:RFC4 | |
| Interaction | NKAP interactions | 9.68e-05 | 132 | 162 | 7 | int:NKAP | |
| Interaction | NBN interactions | 1.19e-04 | 183 | 162 | 8 | int:NBN | |
| Interaction | SRRM1 interactions | NOLC1 ELOA MYH7B BRD3 TIPARP DHX8 MED4 ZNF638 ACIN1 STAG2 CNOT3 | 1.22e-04 | 348 | 162 | 11 | int:SRRM1 |
| Interaction | SNRNP70 interactions | ELOA ABCF1 RBBP6 NAP1L1 RBM28 RFC1 PPIA CWC22 RCC2 DDX1 TIPARP DHX8 CSDE1 PSIP1 TIAM1 PRRC2C MKI67 ZNF638 ACIN1 RBM17 | 1.28e-04 | 984 | 162 | 20 | int:SNRNP70 |
| Interaction | USP53 interactions | 1.28e-04 | 138 | 162 | 7 | int:USP53 | |
| Interaction | POLR1E interactions | NOLC1 ELOA HIVEP1 CENPC NOP53 TAF1C CHD8 BRD3 RBM28 MED4 UTP11 | 1.28e-04 | 350 | 162 | 11 | int:POLR1E |
| Interaction | DHX8 interactions | 1.30e-04 | 292 | 162 | 10 | int:DHX8 | |
| Interaction | SSRP1 interactions | NOLC1 ELOA HIRIP3 ATRX RBBP6 NAP1L1 BRD3 RFC1 TIPARP FANCD2 CSDE1 SHCBP1 ZNF638 ACIN1 TASOR BRWD1 | 1.33e-04 | 685 | 162 | 16 | int:SSRP1 |
| Interaction | FBXW10 interactions | 1.37e-04 | 13 | 162 | 3 | int:FBXW10 | |
| Interaction | SFN interactions | MAPKAP1 NOLC1 NCOA6 RAPGEF6 SASH1 LYST FANCD2 HAUS8 WWC2 DENND1B KCNQ5 TIAM1 PRRC2C SHCBP1 ZNF638 PLCH1 | 1.50e-04 | 692 | 162 | 16 | int:SFN |
| Interaction | RNF113A interactions | NOLC1 ABCF1 DSG1 RBBP6 NAP1L1 RBM28 RFC1 PPIA RCC2 TIPARP CSDE1 FAM193A PRRC2C MKI67 ACIN1 PUM3 | 1.50e-04 | 692 | 162 | 16 | int:RNF113A |
| Interaction | COIL interactions | NOLC1 ELOA HIVEP1 CENPC ZNF174 CHD9 CHD8 BRD3 RBM28 TIPARP DHX8 MKI67 GCC1 STAG2 | 1.53e-04 | 552 | 162 | 14 | int:COIL |
| Interaction | YTHDF3 interactions | 1.74e-04 | 246 | 162 | 9 | int:YTHDF3 | |
| Interaction | FBXW10B interactions | 1.92e-04 | 3 | 162 | 2 | int:FBXW10B | |
| Interaction | BRD7 interactions | NOLC1 HBS1L ABCF1 NAP1L1 BRD3 RFC1 DDX55 PPIA RCC2 DDX1 TIPARP ACSL3 ACSL4 PRRC2C MKI67 | 2.00e-04 | 637 | 162 | 15 | int:BRD7 |
| Interaction | SNRNP40 interactions | ZNF131 HIVEP1 CENPC DSG1 RBBP6 NOP53 RBM28 RFC1 CWC22 RCC2 DHX8 MKI67 ACIN1 TASOR RBM17 | 2.00e-04 | 637 | 162 | 15 | int:SNRNP40 |
| Interaction | ACE2 interactions | TUT4 DSG1 KTN1 UBR4 NAP1L1 PNO1 NBEA RBM28 MDH2 PPIA DDX1 DNAJC2 FABP5 CSDE1 ACSL3 PSIP1 PRRC2C MKI67 ACIN1 NOTCH2 WDR44 | 2.19e-04 | 1106 | 162 | 21 | int:ACE2 |
| Interaction | ZC3H10 interactions | 2.19e-04 | 200 | 162 | 8 | int:ZC3H10 | |
| Interaction | RPS6 interactions | MAPKAP1 NOLC1 ELOA CENPC NOP53 TAF1C NAP1L1 PNO1 BRD3 RBM28 RFC1 DDX55 DNAJC2 TIPARP FANCD2 PSIP1 MKI67 PUM3 | 2.41e-04 | 874 | 162 | 18 | int:RPS6 |
| Interaction | H2BC4 interactions | 2.55e-04 | 259 | 162 | 9 | int:H2BC4 | |
| Interaction | LINC00240 interactions | 2.64e-04 | 16 | 162 | 3 | int:LINC00240 | |
| Interaction | CSNK2A3 interactions | 2.64e-04 | 110 | 162 | 6 | int:CSNK2A3 | |
| Interaction | H2BC9 interactions | PHACTR2 ABCF1 HIVEP1 HIRIP3 ATRX DSG1 MDH2 ACSL4 ZNF469 PSIP1 ANKRD36 KAT6B | 2.69e-04 | 446 | 162 | 12 | int:H2BC9 |
| Interaction | ZNF330 interactions | NOLC1 ELOA CENPC NOP53 NAP1L1 BRD3 RBM28 RFC1 DDX55 PSIP1 PUM3 STAG2 | 2.69e-04 | 446 | 162 | 12 | int:ZNF330 |
| Interaction | TCERG1 interactions | 2.77e-04 | 207 | 162 | 8 | int:TCERG1 | |
| Interaction | RACGAP1 interactions | 2.86e-04 | 208 | 162 | 8 | int:RACGAP1 | |
| Interaction | DRG2 interactions | 3.25e-04 | 74 | 162 | 5 | int:DRG2 | |
| Interaction | PIP4K2A interactions | 3.68e-04 | 216 | 162 | 8 | int:PIP4K2A | |
| Interaction | MAP1A interactions | 3.69e-04 | 117 | 162 | 6 | int:MAP1A | |
| Interaction | PGBD2 interactions | 3.81e-04 | 4 | 162 | 2 | int:PGBD2 | |
| Interaction | TMEM132B interactions | 3.81e-04 | 4 | 162 | 2 | int:TMEM132B | |
| Interaction | CAMKV interactions | 3.86e-04 | 118 | 162 | 6 | int:CAMKV | |
| Interaction | RPL31 interactions | NOLC1 ELOA ERCC5 CENPC NOP53 NAP1L1 BRD3 RBM28 RFC1 DDX55 DHX8 FANCD2 MKI67 ACIN1 PUM3 | 3.99e-04 | 680 | 162 | 15 | int:RPL31 |
| Interaction | SULF2 interactions | 4.04e-04 | 119 | 162 | 6 | int:SULF2 | |
| Interaction | DDRGK1 interactions | RNF130 ELOA HBS1L ABCF1 NOP53 UBR4 NAP1L1 PNO1 RBM28 RFC1 MDH2 DDX55 PPIA CWC22 RCC2 DDX1 DHX8 CSDE1 PSIP1 PRRC2C PUM3 RBM17 | 4.34e-04 | 1249 | 162 | 22 | int:DDRGK1 |
| Interaction | PLCD3 interactions | 4.41e-04 | 121 | 162 | 6 | int:PLCD3 | |
| Interaction | EMC2 interactions | MAPKAP1 RNF130 ABCF1 SPG7 MYH7B KTN1 RFC1 MDH2 FANCD2 ACSL3 RBM17 | 5.06e-04 | 411 | 162 | 11 | int:EMC2 |
| Interaction | RSL1D1 interactions | NOLC1 NOP53 RBM28 DNAJC2 TIPARP DHX8 FANCD2 MED4 UTP11 MKI67 PUM3 RBM17 | 5.10e-04 | 479 | 162 | 12 | int:RSL1D1 |
| Interaction | DCLRE1A interactions | 5.26e-04 | 20 | 162 | 3 | int:DCLRE1A | |
| Interaction | CDK12 interactions | 5.27e-04 | 228 | 162 | 8 | int:CDK12 | |
| Interaction | UTP14A interactions | 5.58e-04 | 230 | 162 | 8 | int:UTP14A | |
| Interaction | SNIP1 interactions | NOLC1 BRD3 RBM28 CWC22 DHX8 CSDE1 UTP11 ACIN1 PUM3 KAT6B RBM17 | 5.71e-04 | 417 | 162 | 11 | int:SNIP1 |
| Interaction | RBM34 interactions | 5.80e-04 | 290 | 162 | 9 | int:RBM34 | |
| Interaction | PRPF3 interactions | 5.94e-04 | 291 | 162 | 9 | int:PRPF3 | |
| Interaction | SPEN interactions | 6.02e-04 | 178 | 162 | 7 | int:SPEN | |
| Interaction | ADARB1 interactions | NOP53 TAF1C CHD8 RBM28 RFC1 DDX55 PPIA DDX1 MKI67 ZNF638 ACIN1 PUM3 | 6.12e-04 | 489 | 162 | 12 | int:ADARB1 |
| Interaction | HCFC1 interactions | 6.24e-04 | 293 | 162 | 9 | int:HCFC1 | |
| Interaction | WWTR1 interactions | NCOA6 HBS1L RAPGEF6 KTN1 NAP1L1 CHD8 JMJD1C CSDE1 PRRC2C DLG1 WDR44 | 6.30e-04 | 422 | 162 | 11 | int:WWTR1 |
| GeneFamily | WD repeat domain containing | 1.74e-05 | 262 | 102 | 9 | 362 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 6.50e-04 | 7 | 102 | 2 | 785 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.11e-03 | 9 | 102 | 2 | 1230 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 1.68e-03 | 11 | 102 | 2 | 559 | |
| GeneFamily | PDZ domain containing | 1.70e-03 | 152 | 102 | 5 | 1220 | |
| GeneFamily | Myosin heavy chains | 3.15e-03 | 15 | 102 | 2 | 1098 | |
| GeneFamily | AAA ATPases | 3.33e-03 | 53 | 102 | 3 | 413 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 3.33e-03 | 53 | 102 | 3 | 103 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TUT4 HIVEP1 SASH1 ATRX CENPC CHD9 NPIPB3 DNAJC2 TIPARP ACSL3 ACSL4 PPP2R3A FAM193A TIAM1 PRRC2C BUB1B ARID5B NAV3 ZNF638 DLG1 PUM3 TMEM131 RAPGEF2 SETD3 KAT6B TASOR STAG2 | 3.23e-12 | 856 | 162 | 27 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TUT4 HIVEP1 ATRX CHD9 NPIPB5 TIPARP ACSL3 PPP2R3A TIAM1 PRRC2C BUB1B ARID5B ZNF638 PUM3 TMEM131 RAPGEF2 KAT6B TASOR | 7.50e-10 | 466 | 162 | 18 | M13522 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | TUT4 ATRX CENPC CHD9 NPIPB5 TIPARP BUB1B ARID5B MKI67 NAV3 ZNF638 RAPGEF2 KAT6B | 5.05e-08 | 300 | 162 | 13 | M8702 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TUT4 RAPGEF6 ERCC5 CENPC KTN1 NAP1L1 NPIPB3 ZNF302 RFC1 PPP2R3A BUB1B MKI67 ZNF638 PUM3 TASOR STAG2 RBM17 | 7.16e-07 | 656 | 162 | 17 | M18979 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TUT4 RAPGEF6 WIPF1 ATRX CENPC RBBP6 SLC26A2 NOP53 KTN1 UBR4 NAP1L1 PPIA LYST JMJD1C CSDE1 ACSL4 KMT2C DENND1B PSIP1 DEF6 ZNF638 KAT6B TASOR STAG2 NOTCH2 BRWD1 | 1.62e-06 | 1492 | 162 | 26 | M40023 |
| Coexpression | SHEPARD_CRASH_AND_BURN_MUTANT_DN | 3.11e-06 | 191 | 162 | 9 | M2148 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 3.48e-06 | 145 | 162 | 8 | M1810 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP | 4.53e-06 | 200 | 162 | 9 | M3277 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | NOLC1 ZNF131 NCOA6 ERCC5 NPIPB15 CENPC RBBP6 NAP1L1 PNO1 PEX13 RFC1 PPIA KLRC4 GRAMD4 DNAJC2 FABP5 PSIP1 TIAM1 PRRC2C PLCL2 MKI67 GATAD1 STAG2 CNOT3 | 5.25e-06 | 1394 | 162 | 24 | M9585 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | RNF130 PHACTR2 ATRX CENPC NEXMIF KTN1 NAP1L1 CHD9 NBEA LYST TMEM132B CSDE1 KMT2C PSIP1 TIAM1 PLCL2 SETD3 KAT6B STAG2 | 6.60e-06 | 946 | 162 | 19 | M39169 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CCPG1 TUT4 RAPGEF6 ATRX TSHZ2 NBEA SSTR2 LYST TMEM132B ANKRD36B ACSL4 PPP2R3A NRXN3 PTPRO NAV3 ANKRD36 SMPD3 RIMS2 TSPYL4 BRWD1 | 1.72e-05 | 1106 | 162 | 20 | M39071 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ZNF131 RNF130 NCOA6 SPG7 ATRX RBBP6 KTN1 PEX13 CHD9 NPIPB3 RBM28 RYR3 ACSL3 ACSL4 BMPR2 UTP11 PLCL2 TMEM131 RAPGEF2 TASOR WIPF2 | 2.04e-05 | 1215 | 162 | 21 | M41122 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.06e-05 | 90 | 162 | 6 | M39250 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | ZNF131 HIVEP1 WIPF1 CENPC RBBP6 PNO1 RFC1 JMJD1C DNAJC2 DHX8 DENND1B PSIP1 RAPGEF2 WIPF2 BRWD1 | 2.24e-05 | 680 | 162 | 15 | M41089 |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP | 3.62e-05 | 200 | 162 | 8 | M8085 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP | 3.62e-05 | 200 | 162 | 8 | M3459 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN | 3.62e-05 | 200 | 162 | 8 | M8427 | |
| Coexpression | GSE17721_CTRL_VS_LPS_4H_BMDC_UP | 3.62e-05 | 200 | 162 | 8 | M3689 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP | 3.62e-05 | 200 | 162 | 8 | M7831 | |
| Coexpression | LIU_CMYB_TARGETS_UP | 7.47e-05 | 164 | 162 | 7 | M15066 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | PPP1R21 SSTR2 LYST TMEM132B ANKRD36B ACSL4 PPP2R3A NRXN3 PTPRO NAV3 SMPD3 RIMS2 | 7.73e-05 | 506 | 162 | 12 | M39067 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | NOLC1 ZNF131 CENPC RBBP6 NAP1L1 PNO1 PPIA DNAJC2 FABP5 PSIP1 PRRC2C BUB1B MKI67 PUM3 CNOT3 | 8.03e-05 | 761 | 162 | 15 | M11961 |
| Coexpression | GABRIELY_MIR21_TARGETS | 8.25e-05 | 289 | 162 | 9 | M2196 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CCPG1 HIVEP1 RBBP6 LYST TIPARP ACSL4 COLEC12 KMT2C WWC2 PTPRO ARID5B UBR3 RAPGEF2 TASOR STAG2 IL6ST | 8.35e-05 | 854 | 162 | 16 | M1533 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | HIRIP3 NEXMIF NBEA RFC1 SSTR2 RCC2 FANCD2 FSD1L PSIP1 PTPRZ1 SHCBP1 BUB1B MKI67 RIMS2 | 8.87e-05 | 680 | 162 | 14 | MM456 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | NOLC1 LDLRAP1 HIRIP3 KATNB1 BRD3 RBM28 RFC1 DDX55 RCC2 DDX1 FABP5 FANCD2 ANKRD36B HAUS8 MED4 UTP11 SHCBP1 BUB1B MKI67 ANKRD36 BAHCC1 | 1.06e-04 | 1363 | 162 | 21 | M45782 |
| Coexpression | SHEPARD_BMYB_TARGETS | 1.10e-04 | 76 | 162 | 5 | M15973 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CCPG1 HIVEP1 RBBP6 LYST TIPARP ACSL4 COLEC12 KMT2C WWC2 PTPRO ARID5B UBR3 RAPGEF2 TASOR STAG2 IL6ST | 1.31e-04 | 888 | 162 | 16 | MM1018 |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 2.12e-04 | 194 | 162 | 7 | M3321 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 2.12e-04 | 194 | 162 | 7 | M7467 | |
| Coexpression | FUJII_YBX1_TARGETS_DN | 2.12e-04 | 194 | 162 | 7 | M14340 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 2.25e-04 | 196 | 162 | 7 | M5381 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN | 2.33e-04 | 197 | 162 | 7 | M7921 | |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP | 2.40e-04 | 198 | 162 | 7 | M8407 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN | 2.47e-04 | 199 | 162 | 7 | M4567 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | NOLC1 CCPG1 PHACTR2 ZNF174 NAP1L1 PNO1 NPIPB3 FSD1L DENND1B PSIP1 PRRC2C GATAD1 PUM3 GCC1 RAPGEF2 PLCH1 | 2.55e-04 | 942 | 162 | 16 | M8144 |
| Coexpression | GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN | 2.55e-04 | 200 | 162 | 7 | M8054 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_BMDM_UP | 2.55e-04 | 200 | 162 | 7 | M5812 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 2.55e-04 | 200 | 162 | 7 | M8090 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN | 2.55e-04 | 200 | 162 | 7 | M4979 | |
| Coexpression | GSE17721_CTRL_VS_LPS_2H_BMDC_DN | 2.55e-04 | 200 | 162 | 7 | M3688 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 2.55e-04 | 200 | 162 | 7 | M7500 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP | 2.55e-04 | 200 | 162 | 7 | M3832 | |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 2.55e-04 | 200 | 162 | 7 | M6252 | |
| Coexpression | GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP | 2.55e-04 | 200 | 162 | 7 | M4093 | |
| Coexpression | GSE3982_DC_VS_BCELL_UP | 2.55e-04 | 200 | 162 | 7 | M5463 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 2.55e-04 | 200 | 162 | 7 | M3188 | |
| Coexpression | GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN | 2.55e-04 | 200 | 162 | 7 | M6949 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | HBS1L RAPGEF6 SPG7 WIPF1 RBBP6 PGBD1 JMJD1C ARID5B RAPGEF2 KAT6B IL6ST | 2.84e-04 | 498 | 162 | 11 | M1741 |
| Coexpression | TABULA_MURIS_SENIS_LIVER_ENDOTHELIAL_CELL_OF_HEPATIC_SINUSOID_AGEING | 2.88e-04 | 418 | 162 | 10 | MM3752 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | PPP1R21 ATRX NEXMIF NAP1L1 NBEA CWC22 ANKRD36B FSD1L PSIP1 ANKRD36 KAT6B WDR44 | 3.05e-04 | 587 | 162 | 12 | M40869 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | HBS1L RAPGEF6 SPG7 WIPF1 RBBP6 PGBD1 JMJD1C ARID5B RAPGEF2 KAT6B IL6ST | 3.30e-04 | 507 | 162 | 11 | MM1030 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 3.53e-04 | 429 | 162 | 10 | M29 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | ELOA CCPG1 RAPGEF6 KTN1 TIPARP FANCD2 BMPR2 MED4 PSIP1 NPIPB13 PRRC2C SHCBP1 RAPGEF2 RIMS2 RBM17 | 3.71e-04 | 877 | 162 | 15 | M2241 |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN | 3.76e-04 | 281 | 162 | 8 | M7089 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NOLC1 NCOA6 KATNAL2 TUT4 ABCF1 ERCC5 HIRIP3 ATRX CENPC RBBP6 KTN1 NAP1L1 PGBD1 PNO1 CHD9 POU3F3 RFC1 CWC22 DNAJC2 TIPARP DHX8 FANCD2 FSD1L NRXN3 FAM193A DENND1B KCNQ5 PSIP1 PTPRZ1 MKI67 RAPGEF2 BRWD1 RBM17 | 7.41e-09 | 1459 | 158 | 33 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NOLC1 NCOA6 KATNAL2 TUT4 ABCF1 ERCC5 HIRIP3 ATRX CENPC RBBP6 KTN1 NAP1L1 PGBD1 PNO1 CHD9 RFC1 DNAJC2 TIPARP DHX8 FANCD2 FSD1L FAM193A DENND1B PSIP1 PTPRZ1 MKI67 RAPGEF2 BRWD1 RBM17 | 4.66e-08 | 1257 | 158 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 LDLRAP1 NCOA6 KATNAL2 TUT4 ABCF1 HIRIP3 ATRX RBBP6 KTN1 POU3F3 CWC22 DNAJC2 ACSL4 FSD1L FAM193A PTPRZ1 PLCH2 MKI67 DNAI4 PUM3 PLCH1 RIMS2 BRWD1 | 3.19e-07 | 989 | 158 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | PPP1R21 ELOA NCOA6 KATNAL2 ABCF1 HIRIP3 ATRX RBBP6 KTN1 PEX13 POU3F3 PLXNB2 DNAJC2 ACSL4 FAM193A DENND1B PTPRZ1 MKI67 DNAI4 | 1.40e-05 | 831 | 158 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | KATNAL2 CCPG1 KTN1 PTPRZ1 PRRC2C ZNF638 ACIN1 RIMS2 WDR44 RBM17 | 2.52e-05 | 259 | 158 | 10 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | ATRX RBBP6 RBM28 DDX55 DNAJC2 PSIP1 PRRC2C ZNF638 PUM3 ANKRD36 RIMS2 | 1.96e-10 | 197 | 164 | 11 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-09 | 184 | 164 | 10 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | PHACTR2 ATRX KTN1 NAP1L1 RFC1 PRRC2C ARID5B ANKRD36 STAG2 BRWD1 | 3.71e-09 | 199 | 164 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-08 | 176 | 164 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-08 | 185 | 164 | 9 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-08 | 191 | 164 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-08 | 191 | 164 | 9 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-08 | 191 | 164 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.44e-07 | 171 | 164 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-07 | 175 | 164 | 8 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.17e-07 | 177 | 164 | 8 | db6de487ef7976b444afadbf3ac60b3259925566 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-07 | 182 | 164 | 8 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.92e-07 | 182 | 164 | 8 | 9ba85f621a846531a2a7861e9df695d288c9e149 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-07 | 186 | 164 | 8 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-07 | 186 | 164 | 8 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.22e-07 | 189 | 164 | 8 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.88e-07 | 192 | 164 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | severe-CD4+_Tcm|World / disease stage, cell group and cell class | 6.11e-07 | 193 | 164 | 8 | be0370b2f0093ad0b9d876297bd196d0160f3d99 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.36e-07 | 194 | 164 | 8 | a7bfc535546d3c1a4e0cbcfeb7da816b34303350 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.61e-07 | 195 | 164 | 8 | 07035a5972a78b98e4ab2167e3a5000f9f3b0826 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.61e-07 | 195 | 164 | 8 | 5001e68df2ad5df9dc93ae235f984ffafea6b521 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.61e-07 | 195 | 164 | 8 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-07 | 195 | 164 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 5'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.87e-07 | 196 | 164 | 8 | a579211ef14f348d0c5a290553150222dfbf1515 | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 7.14e-07 | 197 | 164 | 8 | ec9398ae3577f61d6b1e6aba50ef4261aaaa7610 | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.14e-07 | 197 | 164 | 8 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.14e-07 | 197 | 164 | 8 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.41e-07 | 198 | 164 | 8 | 8a7897d98f5296745d9005a7cd777f0a2f78000d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 7.41e-07 | 198 | 164 | 8 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | T_cells-CCR7+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.70e-07 | 199 | 164 | 8 | 467820d6abe3024d9d655b9672c2f9cdc1303db3 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.70e-07 | 199 | 164 | 8 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.92e-06 | 167 | 164 | 7 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 178 | 164 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.45e-06 | 178 | 164 | 7 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.96e-06 | 181 | 164 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-06 | 182 | 164 | 7 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-06 | 182 | 164 | 7 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.53e-06 | 184 | 164 | 7 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.73e-06 | 185 | 164 | 7 | 406b52516b26e9fe2c9e768950af447ec7ad5f3e | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 5.73e-06 | 185 | 164 | 7 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.73e-06 | 185 | 164 | 7 | f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-06 | 190 | 164 | 7 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.30e-06 | 192 | 164 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.55e-06 | 193 | 164 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.08e-06 | 195 | 164 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.08e-06 | 195 | 164 | 7 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 195 | 164 | 7 | b57132802cb977551e214880984f3edcd375474f | |
| ToppCell | normal-na-Lymphocytic_T-T4_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.35e-06 | 196 | 164 | 7 | feb1c768cf66c64b6c892905d2d865946e70812f | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 8.35e-06 | 196 | 164 | 7 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.35e-06 | 196 | 164 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.63e-06 | 197 | 164 | 7 | 479841809554a9d0b1e4f23da6e657392b0f4971 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.63e-06 | 197 | 164 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-06 | 197 | 164 | 7 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | normal|World / PBMC cell types (v2) per disease, treatment status, and sex | 8.63e-06 | 197 | 164 | 7 | 232e48864aeb5ad6688352383427fb1771986ddc | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.92e-06 | 198 | 164 | 7 | 234c40079bfc93d7c2aa634968d801e9adfb07fd | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.92e-06 | 198 | 164 | 7 | 41342dbe94d6da896669d88152c265438fa9e27d | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.92e-06 | 198 | 164 | 7 | b0b0977d9482538a076b84a8dc8b15ed682662f9 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 8.92e-06 | 198 | 164 | 7 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | Caecum-T_cell-Treg|T_cell / Region, Cell class and subclass | 8.92e-06 | 198 | 164 | 7 | 90a2a75ca078f7088b8739795a9b396113bcbe23 | |
| ToppCell | VE-CD4-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 9.22e-06 | 199 | 164 | 7 | 702e72fa93f18024b02fe3aad92cc1c3b2f6eb68 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.22e-06 | 199 | 164 | 7 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.22e-06 | 199 | 164 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | H1299|World / Cell line, Condition and Strain | 9.53e-06 | 200 | 164 | 7 | 23f08d7cffacfced48785cd3ad230ecadb95713f | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 136 | 164 | 6 | 186be8e1595608004b8216892cb9c7a7f31fbb4d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.06e-05 | 151 | 164 | 6 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.48e-05 | 156 | 164 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.76e-05 | 159 | 164 | 6 | b9d34b9ed8db798f5ea93c44b469cae499403cb8 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 3.06e-05 | 162 | 164 | 6 | 91cc14aec8d580cf97a1929bc1acb00fcbcdb57a | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-05 | 165 | 164 | 6 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-05 | 165 | 164 | 6 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-05 | 165 | 164 | 6 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-GMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.51e-05 | 166 | 164 | 6 | d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.14e-05 | 171 | 164 | 6 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 178 | 164 | 6 | be8af4d85b8835a85a168639c37857dcaa6b00bf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.34e-05 | 179 | 164 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | control-Lymphoid-NKT-proliferating|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.51e-05 | 180 | 164 | 6 | 535535a67b3f3320bad2f98b1bc98a7b0ee77840 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 5.51e-05 | 180 | 164 | 6 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 5.86e-05 | 182 | 164 | 6 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 182 | 164 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | NS-control-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.86e-05 | 182 | 164 | 6 | f623c47e7806181d09f126066a952162ce49a306 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.04e-05 | 183 | 164 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 184 | 164 | 6 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 6.61e-05 | 186 | 164 | 6 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|bone_marrow / Manually curated celltypes from each tissue | 6.61e-05 | 186 | 164 | 6 | 5108d9b7a081876ca34594b110d58df56063f542 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.01e-05 | 188 | 164 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.22e-05 | 189 | 164 | 6 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.43e-05 | 190 | 164 | 6 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 7.43e-05 | 190 | 164 | 6 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.43e-05 | 190 | 164 | 6 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 7.65e-05 | 191 | 164 | 6 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 191 | 164 | 6 | f0c649bb32732c9dd38a0af8ce94d2a4d16de39a | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 191 | 164 | 6 | e518c598719119e60c76016c586b1520c258bbcb | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.87e-05 | 192 | 164 | 6 | 52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.87e-05 | 192 | 164 | 6 | 32927ef3b93e0497e9bbe63c2754da03cf178202 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.87e-05 | 192 | 164 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_TFH-like|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.87e-05 | 192 | 164 | 6 | 0f9cae41bb9bc9366efe9eb48e26b3e80c642879 | |
| ToppCell | CV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 7.87e-05 | 192 | 164 | 6 | a249787f7e2f50af49bd7d4752c411a067a5e3d3 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.87e-05 | 192 | 164 | 6 | 35557254738844c27ffcd00f3287fbcc0a4d0f3b | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 193 | 164 | 6 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_TFH-like|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.10e-05 | 193 | 164 | 6 | 88cc740dd216ea80605b857c27914a8bc6ba6771 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | TUT4 RBBP6 SAP30L CHD8 BRD3 PCTP MED4 PLCL2 BUB1B ZNF638 KAT6B WDR44 | 6.13e-09 | 181 | 160 | 12 | 1791_DN |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | ELOA PHACTR2 SLC26A2 BRD3 BMPR2 PRRC2C RAPGEF2 KAT6B STAG2 IL6ST | 5.77e-07 | 179 | 160 | 10 | 4585_DN |
| Drug | phenethyl isothiocyanate | ZNF131 FBXW10B CCPG1 ERCC5 ATRX CENPC RBBP6 NOP53 KTN1 FANCD2 SHCBP1 BUB1B MKI67 NOTCH2 | 9.88e-07 | 401 | 160 | 14 | ctd:C058305 |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 4.05e-06 | 174 | 160 | 9 | 7530_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | ELOA PHACTR2 RBBP6 SLC26A2 PPP2R3A PRRC2C RAPGEF2 KAT6B IL6ST | 4.88e-06 | 178 | 160 | 9 | 3998_DN |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | NOLC1 ELOA PHACTR2 SLC26A2 PPP2R3A PRRC2C RAPGEF2 KAT6B IL6ST | 7.60e-06 | 188 | 160 | 9 | 6735_DN |
| Drug | Paclitaxel [33069-62-4]; Down 200; 4.6uM; PC3; HG-U133A | 1.06e-05 | 196 | 160 | 9 | 1959_DN | |
| Disease | CXCL5 measurement | 1.69e-05 | 10 | 156 | 3 | EFO_0009422 | |
| Disease | C-X-C motif chemokine 5 measurement | 1.69e-05 | 10 | 156 | 3 | EFO_0008058 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.72e-05 | 152 | 156 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | non-syndromic X-linked intellectual disability 63 (implicated_via_orthology) | 2.78e-05 | 2 | 156 | 2 | DOID:0112050 (implicated_via_orthology) | |
| Disease | chymotrypsin-C measurement | 8.30e-05 | 3 | 156 | 2 | EFO_0802398 | |
| Disease | electrodermal activity measurement | 8.30e-05 | 3 | 156 | 2 | EFO_0006866 | |
| Disease | annexin A6 measurement | 8.30e-05 | 3 | 156 | 2 | EFO_0020151 | |
| Disease | breast cancer (is_implicated_in) | 1.52e-04 | 150 | 156 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | Ischemic stroke, fibrinogen measurement | 2.08e-04 | 55 | 156 | 4 | EFO_0004623, HP_0002140 | |
| Disease | lymphocyte count | ZNF131 HBS1L HIVEP1 PEX13 BRD3 PLXNB2 LYST JMJD1C ZNF469 DENND1B TSBP1 DEF6 ARID5B ZNF638 GATAD1 SETD3 NOTCH2 RBM17 PGBD2 | 2.78e-04 | 1464 | 156 | 19 | EFO_0004587 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | NOLC1 HIVEP1 SPG7 TSHZ2 NBEA TMEM132B BMPR2 NRXN3 DENND1B PLCL2 ARID5B ZNF75A BRWD1 | 3.49e-04 | 801 | 156 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Allergic Reaction | 3.51e-04 | 63 | 156 | 4 | C1527304 | |
| Disease | Hypersensitivity | 3.73e-04 | 64 | 156 | 4 | C0020517 | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 4.11e-04 | 6 | 156 | 2 | DOID:14501 (implicated_via_orthology) | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.45e-04 | 67 | 156 | 4 | C3463824 | |
| Disease | Hematopoetic Myelodysplasia | 4.79e-04 | 29 | 156 | 3 | C2713368 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 5.73e-04 | 7 | 156 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 6.51e-04 | 447 | 156 | 9 | C3714756 | |
| Disease | platelet component distribution width | LDLRAP1 HBS1L WIPF1 ARMC3 BRD3 JMJD1C ACSL3 PRRC2C NOS3 SDHAF4 LRRC71 BRWD1 | 7.09e-04 | 755 | 156 | 12 | EFO_0007984 |
| Disease | holoprosencephaly (is_implicated_in) | 7.62e-04 | 8 | 156 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | Spastic Paraplegia | 9.76e-04 | 9 | 156 | 2 | C0037772 | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 9.76e-04 | 9 | 156 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | mean platelet volume | LDLRAP1 WIPF1 CHD9 BRD3 PPIA CWC22 JMJD1C RCC2 ACSL3 ACSL4 P2RX1 TASOR NOS3 SDHAF4 | 1.08e-03 | 1020 | 156 | 14 | EFO_0004584 |
| Disease | lung cancer (is_marker_for) | 1.15e-03 | 39 | 156 | 3 | DOID:1324 (is_marker_for) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.22e-03 | 10 | 156 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.22e-03 | 10 | 156 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.22e-03 | 10 | 156 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.22e-03 | 10 | 156 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.22e-03 | 10 | 156 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.22e-03 | 10 | 156 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.22e-03 | 10 | 156 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.22e-03 | 10 | 156 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 1.31e-03 | 398 | 156 | 8 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | worry measurement | 1.39e-03 | 154 | 156 | 5 | EFO_0009589 | |
| Disease | Tachycardia, Ventricular | 1.48e-03 | 11 | 156 | 2 | C0042514 | |
| Disease | gastrin-releasing peptide measurement | 1.48e-03 | 11 | 156 | 2 | EFO_0022000 | |
| Disease | Neuroendocrine Tumors | 1.48e-03 | 11 | 156 | 2 | C0206754 | |
| Disease | Bipolar I disorder | 1.48e-03 | 11 | 156 | 2 | C0853193 | |
| Disease | platelet measurement | 1.49e-03 | 315 | 156 | 7 | EFO_0005036 | |
| Disease | hepatocyte growth factor measurement | 1.64e-03 | 44 | 156 | 3 | EFO_0006903 | |
| Disease | biliary liver cirrhosis | 1.64e-03 | 44 | 156 | 3 | EFO_0004267 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 1.77e-03 | 12 | 156 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | Oligospermia | 1.77e-03 | 12 | 156 | 2 | C0028960 | |
| Disease | C-C motif chemokine 28 measurement | 1.77e-03 | 12 | 156 | 2 | EFO_0020199 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.77e-03 | 12 | 156 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.77e-03 | 12 | 156 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 1.99e-03 | 100 | 156 | 4 | C0010606 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.08e-03 | 13 | 156 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Paraganglioma | 2.08e-03 | 13 | 156 | 2 | C0030421 | |
| Disease | melanoma | 2.11e-03 | 248 | 156 | 6 | C0025202 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.23e-03 | 49 | 156 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | autoimmune disease | 2.31e-03 | 173 | 156 | 5 | EFO_0005140 | |
| Disease | Left ventricular noncompaction | 2.42e-03 | 14 | 156 | 2 | C1960469 | |
| Disease | immature platelet count | 2.46e-03 | 106 | 156 | 4 | EFO_0803544 | |
| Disease | Autistic Disorder | 2.72e-03 | 261 | 156 | 6 | C0004352 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.79e-03 | 15 | 156 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.79e-03 | 15 | 156 | 2 | C0154017 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.79e-03 | 15 | 156 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Carcinoma in situ of bladder | 2.79e-03 | 15 | 156 | 2 | C0154091 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 2.95e-03 | 54 | 156 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | leukemia | 3.11e-03 | 55 | 156 | 3 | C0023418 | |
| Disease | smoking status measurement | MAPKAP1 NOLC1 ZNF131 SPG7 TSHZ2 TMEM132B COLEC12 NRXN3 DENND1B PLCL2 ARID5B ZNF75A SETD3 BRWD1 | 3.50e-03 | 1160 | 156 | 14 | EFO_0006527 |
| Disease | fibrinogen measurement, factor VII measurement | 3.61e-03 | 58 | 156 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | Carcinoma of bladder | 4.02e-03 | 18 | 156 | 2 | C0699885 | |
| Disease | Squamous cell carcinoma | 4.32e-03 | 124 | 156 | 4 | C0007137 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKGGIEIVKEKTTRS | 201 | Q13523 | |
| KQGSLKKFKITRGET | 131 | Q6ZS92 | |
| KSGQKSALVKRLKGA | 91 | Q9UKV3 | |
| RSVTGVATKKKKDAV | 341 | Q7L4P6 | |
| TLAELKSKGKKTARA | 226 | O60566 | |
| QSSKIKKGSKGDCTV | 351 | O60488 | |
| SSKLSQKNKVGERKG | 166 | Q86W67 | |
| LKAGGKSTKQAEKQT | 561 | Q8NE71 | |
| SEVKIKRRSVKAKVG | 1721 | Q9P281 | |
| VVKKKGVKRKADTTT | 236 | Q15059 | |
| RKTVQVTGKTRTKEK | 161 | O14627 | |
| RGRKGKKVKSQSTFD | 1531 | Q9HCK8 | |
| VLSKRKGGNVGKSKR | 676 | Q9UKH3 | |
| RISKTKSHGQEKTKG | 561 | A6NCI8 | |
| KTVKFNSKTRDKGEI | 656 | Q12959 | |
| KSGSSKRNKVIKLVD | 501 | Q6IC98 | |
| RINLSKKEGKVVKSS | 91 | Q5XX13 | |
| LSKGKGNKVSAEKVN | 566 | O75534 | |
| GKKDGEISRKVSSQK | 841 | A6QL64 | |
| IARGKKDGEKTKRVS | 906 | A6QL64 | |
| GKKDGEKTRTVSSQK | 1011 | A6QL64 | |
| IKDGEKSGTVSSQKK | 416 | Q8N2N9 | |
| GRNTVLSKSATKEKG | 666 | Q5W041 | |
| RKNTTVPGKKGEEKS | 21 | Q8N535 | |
| GVKRTAKDVIGKAKS | 491 | Q99543 | |
| KEGNGKQKLRQTSKA | 1041 | P78312 | |
| VESLSVQTRKKKGDK | 146 | O75175 | |
| KKRVSSFRGNKIGLK | 126 | Q92617 | |
| TKERVKLEGSKCKGQ | 91 | Q9P258 | |
| LSSEQVSRKKAKGNK | 711 | Q9NW13 | |
| VSRKKAKGNKTETRF | 716 | Q9NW13 | |
| VVSKSGSLKKRKQNE | 576 | Q14978 | |
| AISKLTTRTVKKGDK | 241 | Q86XS8 | |
| KQKHKGRGTVRTVTK | 276 | P55209 | |
| RNFEKSITKLGKKGV | 51 | Q15397 | |
| KKKDQKRLGTGTLRS | 41 | Q7Z3E1 | |
| KNEATVSTGKIAKGK | 131 | Q9Y450 | |
| KKRVSSFRGNKIGLK | 126 | F8W0I5 | |
| SASTLKVNKKTKGLI | 421 | Q8WYB5 | |
| ITKELKTGGKNVSGK | 106 | Q9UPP5 | |
| SGGKNTKIITLNGKK | 11 | Q6ZNQ3 | |
| IKRIVATAKASGKKL | 71 | Q5SW96 | |
| ATAKASGKKLQKVTL | 76 | Q5SW96 | |
| RIDLSKKEGKVVKSS | 91 | O95170 | |
| AKGSRRKKSLSEKVQ | 2126 | Q04721 | |
| TGSKEKGLTKKRTKV | 91 | Q9NZM5 | |
| TKGVEGTDGVKKRKR | 1261 | Q8NEZ4 | |
| RTAKKVEGNKGTKSL | 206 | Q9BW71 | |
| ESKIKGKENKGRSGT | 331 | Q9BXM9 | |
| KKGIEKNLGIGKVSS | 296 | P40926 | |
| SKRQKNKSGETVVLK | 2246 | Q15652 | |
| GKGQITSDKKSREKI | 576 | Q9NR82 | |
| KQLKSISGLVKSKSG | 621 | Q9BVA0 | |
| DVRKKGHGKTRSKEV | 716 | Q9HCG8 | |
| KGLLTTGKRTIKTVD | 576 | Q8NHQ9 | |
| KGKTTIKTGASVLNK | 76 | Q92499 | |
| SGVKEKRKKAASFQT | 681 | A7E2Y1 | |
| KSTIQSKEGGKVTVK | 51 | P13535 | |
| GKSKRGSVKEKERTK | 1601 | O15031 | |
| KTTAGKTGDTKSLNK | 131 | Q8IYT4 | |
| KDGRSVKIIVSISKG | 1911 | Q8IVL0 | |
| KKLGDQTGKKAISTN | 91 | Q5KU26 | |
| GTIKVKATQKKANDG | 526 | Q9Y4C0 | |
| TGSRIITPGEVKKKK | 371 | Q0VF49 | |
| KSSGAVTKKGERAAK | 21 | Q8N4P6 | |
| EGIQKSGTKKLKTET | 261 | Q86UP2 | |
| KSGVIQDALKKSSKG | 311 | Q86UP2 | |
| KKRVSSFRGNKIGLK | 126 | A8MRT5 | |
| GTRATDTKKKKINNG | 41 | Q8N9W4 | |
| SAGVGTGATDTKKKK | 26 | A0A1B0GV03 | |
| TKQQLKASLGKVGVK | 1021 | P46013 | |
| SKAGTVGTTKGKRKT | 256 | O75167 | |
| VGTTKGKRKTDKQPI | 261 | O75167 | |
| KGGKTKFTIENVTRT | 186 | Q9NRX1 | |
| KKRVSSFRGNKIGLK | 126 | O75200 | |
| KLKSIEKARKGAISS | 131 | Q9NPJ6 | |
| TLRNTKIKKGSQKGR | 1871 | P23471 | |
| RGKKNKKSGESSSQL | 86 | Q6ZMI0 | |
| TSKSSGQKGRKELLK | 586 | Q9NY59 | |
| SAKKKDKRVQGGRVI | 21 | Q9BT25 | |
| KKRVSSFRGNKIGLK | 126 | A6NHN6 | |
| KQCIKKKSGSSISEG | 251 | Q06190 | |
| DSRTGKLTLKNKVTK | 436 | Q02413 | |
| DGKESTITRKLKDGK | 101 | Q01469 | |
| KVKGKVRRKVTGTEG | 1246 | Q7Z6E9 | |
| KGSAAKGTGITRKKT | 481 | P29474 | |
| VAEGKKKIKKSVTRN | 671 | Q16827 | |
| KKRVSSFRGNKIGLK | 126 | E5RHQ5 | |
| EKGDSQKGKRKTSEQ | 571 | Q9UQ26 | |
| VSSSKGKGKVDKIGQ | 1811 | Q14686 | |
| KQSLAIESDGKKGSK | 156 | Q9UKL6 | |
| SVIKQGGTKTDKLEK | 431 | Q13467 | |
| RGGIKSKTTAKVTKE | 571 | P46100 | |
| GRKGKKVKTQTSSFD | 1581 | Q3L8U1 | |
| RAKNKSKETFLGSVK | 476 | Q9ULG6 | |
| TVEERKQFKKTGKIS | 356 | A8MPY1 | |
| VVLKSKNTKDGNLGK | 501 | Q96CN9 | |
| KGPTVRTKKVGKNEA | 521 | P40189 | |
| AEKKVSTKGKGRRHI | 106 | Q8WUU5 | |
| VLSKRKGGNVGKSKR | 566 | P61566 | |
| VLSKRKGGNVGKSKR | 566 | P61567 | |
| KTSATALGDKGLKKN | 451 | Q14241 | |
| TISSKRKAKENIGKV | 776 | Q03188 | |
| GKEAKKKIGKSRTTE | 241 | Q8ND61 | |
| QDGKSGSGEKIKKRV | 961 | Q13873 | |
| TDNTKTKRRKTKGKA | 2171 | Q9NSI6 | |
| EKSGKVSKSQLKVLS | 21 | Q9H4E7 | |
| VLSKRKGGNVGKSKR | 676 | P61565 | |
| KQNSLGSSDTLKKGK | 2146 | Q99698 | |
| KRTTAASNKKGGEKE | 636 | Q5VTH9 | |
| VVEQSGKRKSKTKTI | 406 | Q96QF7 | |
| VVLSKRKGGNVGKSK | 676 | Q902F9 | |
| LKNKLKKQSTATGDG | 311 | Q6P3S1 | |
| SQGGKSELVKQSLKK | 36 | Q5VUM1 | |
| QRKLKGNKISISGTK | 21 | O43908 | |
| KRKKRTSIEVSVKGA | 406 | P20264 | |
| STKGQTKRNLAKGKE | 36 | P02775 | |
| KKRVSSFRGNKIGLK | 141 | F8W1W9 | |
| GQRVKVKVLSFTGTK | 316 | Q14562 | |
| GKIERKQKTDGSKTS | 866 | Q9BXW9 | |
| KKRVSSFRGNKIGLK | 126 | A6NJU9 | |
| KAKRKAQGIRTGKCV | 136 | P51575 | |
| KEKVKGVTNQTGLKR | 176 | Q9Y3A2 | |
| SKKVKANTVSGGRNK | 661 | Q8TEU7 | |
| GSRNGKTSKKITIAD | 146 | P62937 | |
| KTKRKSVLAVGKGNV | 771 | Q14DG7 | |
| VQGKRKISPSKKESE | 511 | P35251 | |
| KLEGAGSRTKKKTVV | 131 | Q15572 | |
| ARLKSKKVKAAGQES | 726 | Q5QGS0 | |
| ESKKKINSGSQGATK | 1376 | Q5QGS0 | |
| ENIKKGKKGNVSTIS | 971 | Q8NFP9 | |
| GTKQKRERKKTVSFS | 111 | Q9UPR0 | |
| KRKRLSDSKGKNTCG | 1071 | P28715 | |
| TGQKNSKDSTGKKRE | 1616 | Q9Y520 | |
| RKKQKGLSVTFDGKR | 61 | Q86TU7 | |
| LKAVKRRKGSQKVSG | 306 | Q9BPZ7 | |
| VKILGKRKGRKTVES | 331 | Q92968 | |
| KRKGRKTVESSKVSK | 336 | Q92968 | |
| ASTQKGQIKKKRLSE | 621 | Q8NEM2 | |
| LSALKKKGVRATGTI | 636 | Q96JS3 | |
| RVLAGTAKKSKILSK | 551 | Q9UQ90 | |
| KSSGIRVGSSKRKKS | 236 | P30874 | |
| RVGSSKRKKSEKKVT | 241 | P30874 | |
| KETKGSRGTDQKKNT | 1531 | Q9UK61 | |
| GRKITRIIGFSKKKT | 391 | Q8TED9 | |
| TLADQSSKIKKGSKG | 356 | O95573 | |
| ENENKTKVSGTKRIK | 431 | Q14865 | |
| SILRKKGVKATGTVR | 361 | Q6P3X8 | |
| KKLEKEQTGSKTLNG | 466 | O75475 | |
| EKVNKKSKANTVGGR | 516 | Q9Y4G8 | |
| TVGGRNKLKKILDKT | 526 | Q9Y4G8 | |
| KTTKNEKIKIRTLVG | 471 | Q8IWX7 | |
| KSIRKAISSGEKEKQ | 226 | Q6AWC2 | |
| ELKKSKGGKRSLSNR | 296 | Q15697 | |
| NSVKETGLASKKGLK | 876 | Q13009 | |
| AAKRKIKEKVVTLGG | 616 | P50443 | |
| RGTGKRVLTAKEKKT | 541 | Q8N3U4 | |
| VKSGGQDQERKKTKR | 3341 | Q15413 | |
| VVGSFSRRKKKGSKL | 576 | O75038 | |
| KSNKSRLDQKSEGGK | 166 | Q9HAJ7 | |
| SVEKTSKRGGKIIVG | 266 | Q96I25 | |
| SLKKRGTRSLGKADK | 121 | O94964 | |
| KSRNAQKTKGTSKLV | 1516 | Q92545 | |
| NQKVSKTRGKAKVTG | 281 | P45379 | |
| TDGGRLKQKTTQLKK | 416 | Q5JSH3 | |
| GKKAKEVTTKKRAIS | 146 | Q9UJ04 | |
| SRISLGKKVKSVKET | 446 | O94885 | |
| SKGKKLKKTVTNDRS | 41 | O43516 | |
| LKVTSSASKKGKQLV | 406 | Q9NRE2 | |
| TGIRDKKGVTVKTKS | 1521 | Q4KWH8 | |
| EKGESSTKRKKGQVP | 3781 | Q96JG9 | |
| GKRKRVKLSSGTKDQ | 356 | Q6ZT12 | |
| TTGKNEAKKRKIAET | 136 | P52739 | |
| IQASAGVISKKAKVK | 91 | Q96N20 | |
| KGTKLKKVTNINDRS | 46 | Q8TF74 | |
| SEINGEKSKGSKRAK | 536 | Q5SRN2 | |
| QTKGGNKSTVDFKKR | 711 | Q5TAX3 | |
| ISKVTVKIGDLKRTK | 3571 | Q5T4S7 | |
| LKTKGGITKEVVQKG | 451 | Q6NT04 | |
| TKKVKIQGRGASGIS | 1216 | Q6ZQQ6 | |
| TSESLKGVKRKKIVA | 41 | P15822 | |
| TVAVKGNKASIKTAK | 821 | Q14966 | |
| SGGKKSLEAKKTGNV | 836 | Q14966 | |
| SKKSVIKSERINGGK | 236 | Q9NR11 |